Topic

Author/Academic

Viewpoint

Source

Summarizes the history of the development of the morality objections in the context of biotechnology patents.

Current approaches to morality within the EU and globally are diverse. Warren-Jones argues that there is a need for a common approach to be developed worldwide, and that the EPO is in a position to do this, but in fact its judgments have induced confusion.

Biotechnology patents and morality

Enrico Bonadio

Considers the implications of the Brüstle decision in this ongoing debate. The potential for a challenge to the EU under WTO rules is noted.

‘Biotech Patents and Morality after Brustle’ (2012) 34(7) EIPR 433–443